MRM NASDAQ
MEDIROM Healthcare Technologies Inc.
1W: -16.3%
1M: -34.8%
3M: -39.8%
YTD: -68.4%
1Y: -70.5%
3Y: -89.7%
5Y: -94.5%
$0.62
-0.04 (-6.12%)
Weekly Expected Move ±9.1%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$8.3B
+21.5% ▲
5Y CAGR: +16.3%
Gross Profit
$2.2B
+43.2% ▲
5Y CAGR: +18.8%
Operating Income
-$18M
+95.4% ▲
Net Income
$149M
+29.3% ▲
5Y CAGR: +53.7%
EPS (Diluted)
$28.52
+28.1% ▲
5Y CAGR: +47.7%
EBITDA
$387M
+25.0% ▲
5Y CAGR: +25.4%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $3.3B | $5.4B | $7.0B | $6.8B | $8.3B |
| YoY Growth | -14.5% | +61.9% | +28.5% | -1.8% | +21.5% |
| Cost of Revenue | $2.9B | $4.0B | $5.1B | $5.3B | $6.1B |
| Gross Profit | $429M | $1.4B | $1.9B | $1.6B | $2.2B |
| Gross Margin | 12.8% | 26.2% | 27.4% | 23.0% | 27.1% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1.1B | $1.8B | $1.8B | $2.0B | $2.2B |
| Operating Expenses | $1.2B | $1.9B | $1.8B | $2.0B | $2.3B |
| Operating Income | -$746M | -$471M | $97M | -$392M | -$18M |
| Operating Margin | -22.3% | -8.7% | 1.4% | -5.7% | -0.2% |
| Interest Expense | $13M | $12M | $10M | $37M | $50M |
| Income Before Tax | -$627M | -$414M | $180M | $21M | $48M |
| Tax Expense | -$88M | $576M | $31M | -$94M | -$90M |
| Net Income | -$539M | -$991M | $149M | $115M | $149M |
| Net Margin | -16.1% | -18.3% | 2.1% | 1.7% | 1.8% |
| EPS (Diluted) | $-133.97 | $-203.13 | $27.23 | $22.27 | $28.52 |
| EBITDA | -$551M | -$276M | $374M | $310M | $387M |
| Shares Outstanding | 4M | 5M | 5M | 5M | 6M |